Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Breathalyzer-Type Device Could Identify Scent in Breath Altered by COVID-19

By LabMedica International staff writers
Posted on 18 Dec 2020
A breath-testing device similar to a Breathalyzer – which tests blood alcohol levels – could detect COVID-19 immediately with ease and speed, allowing for scores of people to be tested in a short amount of time.

A team of researchers from IUPUI (Indiana University–Purdue University Indianapolis; Indianapolis, IN, USA) is developing a COVID-19 breath-testing device based o the same methodology used in training dogs to sniff out prostate cancer molecules from urine samples. More...
The team is developing a sensor that would identify the scent in breath altered by COVID-19. However, it would be different from how alcohol Breathalyzers work as they measure the level of alcohol in one's breath, which correlates to alcohol in the blood. The researchers are now collecting breath samples from people who have tested positive, including asymptomatically, and negative for COVID-19.

Portable blood-alcohol Breathalyzers that can be attached to a keychain can be purchased online for under USD 50, and the researchers believe that a similar device for COVID-19 could be just as inexpensive once it enters mass production. The team is currently using trained dogs with the capability to sniff out prostate cancer molecules from urine samples, preventing unnecessary biopsies for patients.

"We have the unique perspective of identifying a signature. We're looking at the metabolic pathways the virus causes, which can be identified," said Mangilal Agarwal from the School of Engineering and Technology who is leading the team. "This technology, or proof of it, could help not only with COVID-19 but with other infectious diseases."

Related Links:
IUPUI


Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.